Literature DB >> 16763152

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.

Norman L Letvin1, John R Mascola, Yue Sun, Darci A Gorgone, Adam P Buzby, Ling Xu, Zhi-Yong Yang, Bimal Chakrabarti, Srinivas S Rao, Jörn E Schmitz, David C Montefiori, Brianne R Barker, Fred L Bookstein, Gary J Nabel.   

Abstract

Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV)-infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4+ T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763152      PMCID: PMC2365913          DOI: 10.1126/science.1124226

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

1.  Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.

Authors:  P S Polacino; V Stallard; J E Klaniecki; S Pennathur; D C Montefiori; A J Langlois; B A Richardson; W R Morton; R E Benveniste; S L Hu
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

Review 3.  Progress toward an HIV vaccine.

Authors:  Norman L Letvin
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

4.  Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.

Authors:  Sampa Santra; Michael S Seaman; Ling Xu; Dan H Barouch; Carol I Lord; Michelle A Lifton; Darci A Gorgone; Kristin R Beaudry; Krisha Svehla; Brent Welcher; Bimal K Chakrabarti; Yue Huang; Zhi-Yong Yang; John R Mascola; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes.

Authors:  Yue Sun; Jörn E Schmitz; Paula M Acierno; Sampa Santra; Ramu A Subbramanian; Dan H Barouch; Darci A Gorgone; Michelle A Lifton; Kristin R Beaudry; Kelledy Manson; Valerie Philippon; Ling Xu; Holden T Maecker; John R Mascola; Dennis Panicali; Gary J Nabel; Norman L Letvin
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

6.  Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen.

Authors:  P Polacino; V Stallard; J E Klaniecki; D C Montefiori; A J Langlois; B A Richardson; J Overbaugh; W R Morton; R E Benveniste; S L Hu
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

8.  Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys.

Authors:  Michael S Seaman; Sampa Santra; Michael H Newberg; Valerie Philippon; Kelledy Manson; Ling Xu; Rebecca S Gelman; Dennis Panicali; John R Mascola; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.

Authors:  Michael S Seaman; Ling Xu; Kristin Beaudry; Kristi L Martin; Margaret H Beddall; Ayako Miura; Anna Sambor; Bimal K Chakrabarti; Yue Huang; Robert Bailer; Richard A Koup; John R Mascola; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

10.  HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine.

Authors:  Peter B Gilbert; Marta L Ackers; Phillip W Berman; Donald P Francis; Vladimir Popovic; Dale J Hu; William L Heyward; Faruk Sinangil; Bryan E Shepherd; Marc Gurwith
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

View more
  190 in total

Review 1.  Natural SIV hosts: showing AIDS the door.

Authors:  Ann Chahroudi; Steven E Bosinger; Thomas H Vanderford; Mirko Paiardini; Guido Silvestri
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

2.  Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.

Authors:  Hiroshi Ishii; Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Saori Matsuoka; Teiichiro Shiino; Akiko Takeda; Makoto Inoue; Akihiro Iida; Hiroto Hara; Tsugumine Shu; Mamoru Hasegawa; Taeko K Naruse; Akinori Kimura; Masafumi Takiguchi; Tetsuro Matano
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression.

Authors:  Swarali Kurle; Madhuri Thakar; Ashwini Shete; Ramesh Paranjape
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

4.  HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.

Authors:  Jennifer M Pfaff; Craig B Wilen; Jessamina E Harrison; James F Demarest; Benhur Lee; Robert W Doms; John C Tilton
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

5.  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.

Authors:  Lauren A Hirao; Ling Wu; Abhishek Satishchandran; Amir S Khan; Ruxandra Draghia-Akli; Adam C Finnefrock; Andrew J Bett; Michael R Betts; Danilo R Casimiro; Niranjan Y Sardesai; J Joseph Kim; John W Shiver; David B Weiner
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

6.  Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

Authors:  Bangxing Hong; Xiao-Tong Song; Lisa Rollins; Lindsey Berry; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

7.  Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.

Authors:  Sunil Kannanganat; Pragati Nigam; Vijayakumar Velu; Patricia L Earl; Lilin Lai; Lakshmi Chennareddi; Benton Lawson; Robert L Wilson; David C Montefiori; Pamela A Kozlowski; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

8.  Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop.

Authors:  Dean Follmann; Ann Duerr; Stephen Tabet; Peter Gilbert; Zoe Moodie; Patricia Fast; Massimo Cardinali; Steve Self
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

9.  Immunologic and virologic events in early HIV infection predict subsequent rate of progression.

Authors:  Anuradha Ganesan; Pratip K Chattopadhyay; Tess M Brodie; Jing Qin; Wenjuan Gu; John R Mascola; Nelson L Michael; Dean A Follmann; Mario Roederer
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

10.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.